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ABSTRACT
Background: Lifestyle and life-environment factors have undergone drastic changes in Japan over the last few decades. Further,
many molecular epidemiologic studies have reported that genetic, epigenetic, and other biomarker information may be useful in
predicting individual disease risk.
Methods: The Japan Public Health Center-based Prospective Study for the Next Generation (JPHC-NEXT) was launched in
2011 to identify risk factors for lifestyle-related disease, elucidate factors that extend healthy life expectancy, and contribute
toward personalized healthcare based on our more than 20 years’ experience with the JPHC Study. From 2011 through 2016, a
baseline survey was conducted at 16 municipalities in seven prefectures across the country. A self-administered questionnaire
was distributed to all registered residents aged 40–74, which mainly asked about lifestyle factors, such as socio-demographic
situation, personal medical history, smoking, alcohol and dietary habits. We obtained informed consent from each participant to
participate in this long follow-up study of at least 20 years, including consent to the potential use of their residence registry,
medical records, medical fee receipts, care insurance etc., and to the provision of biospecimens (blood and urine), including
genomic analysis.
Results: As of December 31, 2016, we have established a population-based cohort of 115,385 persons (Response rate 44.1%),
among whom 55,278 (47.9% of participants) have provided blood and urine samples. The participation rate was slightly higher
among females and in the older age group.
Conclusion: We have established a large-scale population-based cohort for next-generation epidemiological study in Japan.
Key words: JPHC-NEXT; population-based cohort; genomic research
Copyright © 2019 Norie Sawada et al. This is an open access article distributed under the terms of Creative Commons Attribution License, which
permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
INTRODUCTION
Elucidating preventive factors against barriers to a healthy life,
such as cancer and cardiovascular disease—major causes of death
which lower quality of life (QOL)—is important in expanding
healthy life expectancy in Japan.1 Beginning in 1990, we have
conducted the Japan Public Health Center-based Prospective
Study (JPHC Study),2 consisting of 140,000 residents aged 40
through 69 years who lived within 11 public health center-based
areas nationwide in 1990–1994. The JPHC Study has since
yielded more than 300 papers published on associations between
potential etiologic factors and the incidence of or mortality from
cancer, cardiovascular disease and other diseases associated with
shorter life expectancy.
However, lifestyle and life-environment factors among the
Japanese population have undergone drastic changes during these
decades,3 and many molecular epidemiological studies have
reported associations between genetic and environmental factors
and diseases4–6 and identiﬁed biomarkers that may be useful in
predicting disease risk in individuals.7,8 The addition of such
biomarker information to environmental factors will be helpful in
establishing personalized healthcare.
Japan has experienced a rapid aging of the population,
resulting from a decline in the birthrate.1 In 2017, the proportion
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of deaths due to cancer, heart disease, and cerebrovascular disease
were 28.7%, 15.2%, and 9.4%, respectively. In addition, the 2016
Comprehensive Survey of Living Conditions in Japan showed
that dementia and fractures or falls are the major causes of the
need for assistance or long-term care, accounting for 24.8% and
10.8% of in-home recipients, respectively.9 Given that average
life expectancy in Japan is already among the highest in the
world10 and is increasing,1 eﬀorts to extend healthy life
expectancy will require the elucidation of preventive factors for
not only life-style related diseases but also functional disability.
Therefore, research on the extension of healthy life expectancy in
an aging society is an urgent issue.
In 2011, we launched the JPHC Study for the Next Generation
(JPHC-NEXT). This large-scale, population-based prospective
study has been designed to identify risk factors for lifestyle-
related disease, elucidate factors that extend healthy life
expectancy, and contribute toward personalized healthcare.
METHODS
Organization
The organization of JPHC-NEXT is listed in Figure 1. A Steering
Committee was organized to manage and control the progress of
the study. A central oﬃce was established at the National Cancer
Center, and regional oﬃces were established in each of the local
areas involved. Regional oﬃces were selected from among public
health centers and universities able to play a role in managing
collaboration with municipalities and hospitals in each area. The
study protocol of JPHC-NEXT was developed by the research
members of JPHC-NEXT and approved by the Institutional
Review Board of the National Cancer Center, as well as at each
collaborating university in the regional areas.
Cohort subjects
The JPHC-NEXT is being conducted under a population-based
cohort design in 16 municipalities of seven prefectural areas
across Japan, namely the Ninohe=Karumai area (Ninohe City and
Karumai Town in Iwate Prefecture), Yokote area (Yokote City in
Akita Prefecture), Saku area (Saku City, Sakuho Town, Koumi
Town, Minamimaki Village, Minamiaiki Village, Kitaaiki Village
and Kawakami Village in Nagano Prefecture), Chikusei area
(Chikusei City in Ibaraki Prefecture), Konan=Aki area (Kagami
and Noichi districts in Konan City and Aki City in Kochi
Prefecture), Ozu area (Ozu City in Ehime Prefecture) and Unzen=
Minamishimabara area (Unzen City and Minamishimabara City
in Nagasaki Prefecture) (Figure 2). Among these seven areas,
the Ninohe=Karumai, Yokote, Saku, and Konan areas are also
participating in the JPHC Study. However, the areas of the
Ninohe=Karumai, Yokote, and Saku municipalities are larger
than they were in the JPHC Study because of municipal mergers
occurring in 2005–2006. All areas were selected in consideration
of geographical distribution, size, and feasibility.
The target population for the JPHC-NEXT is the total of
261,939 residents (130,602 men and 131,337 women) aged
40–74 years who were registered in the basic residence registers
of the 16 municipalities at the time of enrollment in 2011–2016.
The inclusion criteria for the JPHC-NEXT are persons who
consent to participate in the study.
Baseline survey
Questionnaire
We distributed a self-administered questionnaire to the entire
target population at the time of enrollment and asked each partic-
ipant to report their lifestyle and social factors, such as personal
medical history, smoking, alcohol drinking, dietary habits, social
support, social network, psychological health, educational level,
and income.11 The dietary habits component of this questionnaire
is a comprehensive validated food frequency questionnaire (FFQ)
that includes 172 food items.12 We distributed the questionnaire
via the following methods: 1) through related community organ-
izations within each municipality, 2) at health check-ups, and 3)
by mail. Incomplete answers were supplemented by telephone
Figure 1. Organization of the Japan Public Health Center-based Prospective Study for the Next Generation (JPHC-NEXT)
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interview or mail; or, incomplete answers for participants of health
check-ups were conﬁrmed via face-to-face interview, telephone
interview, or mail, in accordance with our manual.
Based on evidence from the JPHC Study, we encouraged
responding participants to adopt healthy behaviors by providing
each with individualized analyses of their personal data, titled
“10-year cumulative probability of the occurrence of cancer and
cardiovascular disease”13 and “Diet intake”. Additionally, we
rewarded participants who answered the questionnaire with a
prepaid shopping card of 1,000 yen equivalent value.
Blood and urine
We collected 7mL of blood using an EDTA tube and 4mL of
urine from participants under informed consent on the following
occasions. First, we collected biospecimens at speciﬁc health
check-ups conducted for persons aged 40 through 74 years under
the National Health Insurance. Second, to cover subjects who
do not receive speciﬁc health check-ups, we also collected
these biospecimens at comprehensive medical examinations or
occasions organized speciﬁcally for blood and urine donation for
this study. The tube was centrifuged for 10min at 3,500–
4,000 rpm as soon as possible after collection, and the plasma,
erythrocyte, and buﬀy layers were divided into ﬁve 1.0mL tubes
(three for the plasma and one each for erythrocyte and buﬀy
layers). Urine samples were stored in 4.0mL tubes. All samples
were stored at −80°C. Biospecimens were collected within about
1 year of the completion of the questionnaire.
Based on evidence from the JPHC Study,14 we provided
subjects with the results for “10-year cumulative probability
of gastric cancer occurrence,” obtained by measuring serum
immunoglobulin G antibodies to Helicobacter pylori and blood
levels of pepsinogen. Serums were derived from the biospeci-
mens for the health examinations or the residuals of blood
collected at occasions organized speciﬁcally for blood donation
for this study. We stored the residuals of serum samples using the
same method as for plasma.
Follow-up system
Participants are being followed for vital status (or cause of death),
migration, and the occurrence of cancer, other potentially
lifestyle-related diseases, and need for support=long-term care
certiﬁcation.
Vital status and migration
Information on the vital status and migration of participants is
centralized from municipalities in the research areas to the central
oﬃce with the help of the regional oﬃces. For participants
who move out the research area, the central oﬃce refers to the
certiﬁcate of residence and vital status at their new address with
the consent of participants. The cause of death of participants is
conﬁrmed using death certiﬁcates in public health centers in each
area, with the permission of the Ministry of Health, Labour and
Welfare. Regional centers collect information on cause of death
and send it to the central oﬃce annually.
Incidence of lifestyle-related diseases
The 2013 Cancer Registry Promotion Act made cancer reporting
a legal requirement of hospitals from 2016. Therefore, a cancer
registry is available to conﬁrm the incidence of cancer among our
study participants. However, the cancer registry does not include
information on all cancer subtype variables that might inﬂuence
risk, such as estrogen receptor status for breast cancer or Gleason
score for prostate cancer and so on. Accordingly, incidence data
of cancer from 2011 to 2015 and information of cancer subtypes
were obtained using data from local major hospitals, in addition
to population-based cancer registry data. Regarding cardiovas-
cular diseases (coronary heart disease, stroke, congestive heart
failure, and aortic disease), we ﬁrst categorized candidate cases
using the diagnosis from the inpatient medical record and=or
medical expenses. A physician or researcher then extracted
detailed information from the medical record, including imaging,
into cohort-speciﬁc registration forms at major hospitals in the
research areas. In addition, we deﬁned subjects who needed
Support=Long-Term Care certiﬁcation and those with dementia
using the public long-term care insurance, with disabling
dementia identiﬁed in persons with disease of grade ≥IIa under
this system, as previously reported.15 To conﬁrm other lifestyle-
related diseases, we are currently considering the use of electronic
medical records and medical expenses.
Saku (Nagano)
Yokote (Akita)
Ninohe/Karumai (Iwate)
Chikusei (Ibaraki)
Konan/Aki (Kochi)Ozu (Ehime)
Unzen/Minamishimabara
(Nagasaki)
Figure 2. Map of the JPHC-NEXT Study
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Follow-up surveys
After the baseline survey, two follow-up surveys are scheduled
to be conducted at 5-year intervals to assess changes in lifestyle
and life-environmental factors, including diet and disease history,
using a questionnaire. To objectively evaluate changes in
lifestyle, health, DNA methylation, and other factors, we are
planning to collect blood and urine every 5 years. The research
schedule is shown in Figure 3.
Informed consent
Signed informed consent was obtained from all participants to
participate in this long follow-up study, including consent for the
collection of information on medical history, medical expenses,
care insurance, support=long-term care certiﬁcation, cancer
registry, residence registry, and death certiﬁcate, and for the use
of biospecimens for research, including genome analysis.
RESULTS
Participants
Among a total of 261,939 residents (130,602 men and 131,337
women) aged 40–74 years in the research areas, 115,385 persons
(44.1% of total residents; 53,210 men and 62,175 women)
consented to participate in the study. The consent rate in women
(47.3%) was higher than that in men (40.7%) (Table 1, Table 2,
and Table 3). The area-speciﬁc proportion of consent ranged
from 14.7% to 74.5% in total participants, from 14.2% to 71.4%
in men, and from 15.2% to 81.7% in women. The median
recruitment year was 2014 (Figure 4).
Among participants, 55,278 persons consented to the use of
their biospecimens for this research, including genome analysis
(47.9%). The proportion of persons who provided biospecimens
was higher in women (51.0%) than in men (44.3%). The range of
area-speciﬁc proportion of provision of biospecimens among
participants was from 33.4% to 65.6% in total participants, from
29.7% to 60.4% in men, and from 36.4% to 69.9% in women. The
proportion of specimens provided by women (31,682 women,
57.3%) was higher than that by men (23,596 men, 42.7%).
Regarding age distribution, participants in the JPHC-NEXT
were slightly older than the overall population in the study area,
and a slightly higher proportion of older subjects provided
biospecimens (Figure 5).
We compared the baseline characteristics of JPHC-NEXT and
JPHC subjects in the same age group (40–59 years). Among these
subjects, men in JPHC-NEXT tended to smoke less and drink less
alcohol than those in the JPHC Study, while women tended to
smoke more and drink more alcohol. Mean height and weight
were higher in JPHC-NEXT than in the JPHC Study in both men
and women. Although mean BMI in men was higher in JPHC-
NEXT than in the JPHC Study, mean BMI in women was lower.
Mean age at menarche was lower in JPHC-NEXT than in the
JPHC Study (eTable 1).
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DISCUSSION
The JPHC-NEXT incorporates 16 study areas (city, town, or
village level) from 7 prefectures. The participation rate has tended
to be higher in towns and villages than in the cities, and varied
with the method of questionnaire distribution. When question-
naires were distributed by local community organizations
administered by or associated with the respective municipality,
the participation rate was moderately high, but when question-
naires were distributed by mail, it was very low (less than 20%).
We tried to distribute the questionnaire by hand, but some
municipalities had only small communities and we could not
access all target areas by hand. Even though local community
organizations distributed questionnaire at the time of JPHC Study
in the same areas, the members of active organizations had
substantially decreased over the subsequent 20 years. As in the
JPHC Study, participation rates were lower in men than in
women.16
The speciﬁc health check-ups conducted at annual community
health examinations, which are conducted by municipalities,17
represent an eﬃcient means of sourcing biospecimens and to
obtain informed consent in a face-to-face manner, because these
involve the assembly at a speciﬁc date and place of large numbers
of people who are registered to receive National Health
Insurance. However, collection at these health check-ups might
lead to a degree of bias, because they are more frequently
attended by women than men, who more commonly undergo
health check-ups at their workplace or at a comprehensive
medical examination supported by their employer. Indeed, we
saw a gender diﬀerence in the collection rates of blood samples
(62.9% in women and 37.1% in men) in the JPHC.16 To attenuate
such bias in the JPHC-NEXT, we also collected biospecimens at
comprehensive medical examinations or organized occasions
speciﬁcally for blood and urine donation for this study. Bias was
accordingly less than with the JPHC, albeit that the proportion of
participants providing biosamples was still higher in women
(57.3% in women, 42.7% in men). Although our participation rate
was not particularly high (44.1% of the total target population),
the age distribution of participants of the JPHC-NEXT was
similar to that in the overall population in the study areas.
Accordingly, the JPHC-NEXT is not biased with regard to age
distribution. However, we cannot rule out the possibility that the
moderate participation rate might have lead to a degree of bias
with regard to lifestyle, incidence, or mortality. Additionally,
subjects who provided biospecimens were slightly biased toward
older age. Moreover, people who attend health check-ups tend to
be health-conscious. Any generalization of the results should,
therefore, be done with caution.18,19
Response rate in the JPHC Study was higher (81%)2 than
that in JPHC-NEXT. In the 1990s, no ethical guidelines for
epidemiological studies were available in Japan. Collection of
written informed consent was not necessary; rather, response to
a questionnaire was recognized as consent. This represents a
substantial diﬀerence between JPHC and JPHC-NEXT. The
Table 2. Population in municipalities and number of participants in JPHC-NEXT, males
Regional Oﬃce Study Area
Total population
in Study Area (a)
Number of
participants (b)
Proportion of
participants
(b=a+100) (%)
Number of subjects
who provided
biospecimens (c)
Proportion of subjects
who provided
biospecimens (c=b+100) (%)
Iwate Medical University
Ninohe=Karumai Area in
Iwate Prefecture
Subtotal 9,498 4,954 52.2 1,750 35.3
Ninohe City 6,941 3,434 49.5 1,169 34.0
Karumai Town 2,557 1,520 59.4 581 38.2
Yokote Public Health Center
Yokote Area in Akita
Prefecture
Subtotal 22,574 14,011 62.1 7,138 50.9
Yokote City 22,574 14,011 62.1 7,138 50.9
Saku Public Health Center
Saku Area in Nagano
Prefecture
Subtotal 28,581 14,881 52.1 5,807 39.0
Saku City 22,410 11,034 49.2 3,826 34.7
Sakuho Town 2,851 1,776 62.3 960 54.1
Koumi Town 1,195 813 68.0 309 38.0
Minamimaki Village 743 328 44.1 198 60.4
Kitaaiki Village 175 125 71.4 60 48.0
Minamiaiki Village 245 166 67.8 91 54.8
Kawakami Village 962 639 66.4 363 56.8
Osaka University
and University of Tsukuba
Chikusei Area in Ibaraki
Prefecture
Subtotal 27,856 7,812 28.0 4,102 52.5
Chikusei City 27,856 7,812 28.0 4,102 52.5
Kochi University
Konan=Aki Area in Kochi
Prefecture
Subtotal 9,942 3,308 33.3 1,561 47.2
Kagami and Noichi
districts in Konan City
5,395 1,616 30.0 646 40.0
Aki City 4,547 1,692 37.2 915 54.1
Ehime University
Ozu Area in Ehime
Prefecture
Subtotal 10,552 2,955 28.0 1,324 44.8
Ozu City 10,552 2,955 28.0 1,324 44.8
Nagasaki University
Unzen=Minamishimabara
Area in Nagasaki Prefecture
Subtotal 21,599 5,289 24.5 1,914 36.2
Unzen City 10,463 1,482 14.2 782 52.8
Minamishimabara City 11,136 3,807 34.2 1,132 29.7
Total 130,602 53,210 40.7 23,596 44.3
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lower response rate in JPHC-NEXT partly suggests that the
provision of informed consent was a burden for participants.
The JPHC-NEXT uses the same or a similar questionnaire to
those of the Tohoku Medical Megabank Project20 and some other
cohort studies, such as the Murakami Cohort Study,21 Uonuma
cohort,22 Yamagata study,23 and Chiba cohort.24 Additionally, we
have considered how to integrate our questionnaire with the
slightly diﬀerent questionnaire used by the Japan Multi-Institu-
tional Collaborative Cohort Study (J-MICC Study).25 Collabo-
ration and integration with domestic and international genome
% Number 
of participants
Figure 4. Recruitment of participants in the JPHC-NEXT Study
Table 3. Population in municipalities and number of participants in JPHC-NEXT, females
Regional Oﬃce Study Area
Total population
in Study Area (a)
Number of
participants (b)
Proportion of
participants
(b=a+100) (%)
Number of subjects
who provided
biospecimens (c)
Proportion of subjects
who provided
biospecimens (c=b+100) (%)
Iwate Medical University
Ninohe=Karumai Area in
Iwate Prefecture
Subtotal 9,249 5,618 60.7 2,478 44.1
Ninohe City 6,954 4,000 57.5 1,718 43.0
Karumai Town 2,295 1,618 70.5 760 47.0
Yokote Public Health Center
Yokote Area in Akita
Prefecture
Subtotal 23,390 15,865 67.8 8,878 56.0
Yokote City 23,390 15,865 67.8 8,878 56.0
Saku Public Health Center
Saku Area in Nagano
Prefecture
Subtotal 27,858 16,597 59.6 7,261 43.7
Saku City 21,934 12,379 56.4 4,836 39.1
Sakuho Town 2,769 1,917 69.2 1,143 59.6
Koumi Town 1,190 934 78.5 394 42.2
Minamimaki Village 691 389 56.3 272 69.9
Kitaaiki Village 170 132 77.6 83 62.9
Minamiaiki Village 229 187 81.7 119 63.6
Kawakami Village 875 659 75.3 414 62.8
Osaka University
and University of Tsukuba
Chikusei Area in Ibaraki
Prefecture
Subtotal 27,147 9,511 35.0 5,999 63.1
Chikusei City 27,147 9,511 35.0 5,999 63.1
Kochi University
Konan=Aki Area in Kochi
Prefecture
Subtotal 10,492 4,147 39.5 2,216 53.4
Kagami and Noichi
districts in Konan City
5,756 2,092 36.3 921 44.0
Aki City 4,736 2,055 43.4 1,295 63.0
Ehime University
Ozu Area in Ehime
Prefecture
Subtotal 10,869 4,044 37.2 2,212 54.7
Ozu City 10,869 4,044 37.2 2,212 54.7
Nagasaki University
Unzen=Minamishimabara
Area in Nagasaki Prefecture
Subtotal 22,332 6,393 28.6 2,638 41.3
Unzen City 10,672 1,625 15.2 904 55.6
Minamishimabara City 11,660 4,768 40.9 1,734 36.4
Total 131,337 62,175 47.3 31,682 51.0
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cohorts is important in achieving our aim of contributing to the
development of personalized healthcare.
In conclusion, the JPHC-NEXT has been undertaken to reveal
risk factors for lifestyle-related disease and to contribute toward
personalized healthcare. The JPHC-NEXT Study is expected to
provide evidence for the extension of healthy life expectancy of
future generations of the Japanese population.
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